Weaver C. Barksdale & Associates Inc. Cuts Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Weaver C. Barksdale & Associates Inc. cut its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,024 shares of the real estate investment trust’s stock after selling 463 shares during the period. Weaver C. Barksdale & Associates Inc.’s holdings in Omega Healthcare Investors were worth $1,063,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Versant Capital Management Inc purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at about $26,000. WFA Asset Management Corp purchased a new position in Omega Healthcare Investors in the first quarter worth approximately $39,000. Covestor Ltd lifted its stake in Omega Healthcare Investors by 47.6% in the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after acquiring an additional 431 shares during the last quarter. Highlander Capital Management LLC grew its holdings in Omega Healthcare Investors by 52.0% during the 1st quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock worth $60,000 after acquiring an additional 650 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Omega Healthcare Investors by 93.4% in the 2nd quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock valued at $84,000 after purchasing an additional 1,181 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Trading Down 2.0 %

OHI opened at $40.48 on Friday. The firm has a market cap of $10.44 billion, a price-to-earnings ratio of 36.47, a price-to-earnings-growth ratio of 1.49 and a beta of 1.00. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.53. The business’s 50 day moving average is $38.09 and its two-hundred day moving average is $33.88. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The business had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business’s revenue was up 17.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.74 earnings per share. On average, research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.62%. Omega Healthcare Investors’s payout ratio is 241.44%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on OHI. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price target for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Wells Fargo & Company upgraded Omega Healthcare Investors to a “strong-buy” rating in a report on Friday, June 14th. Finally, Scotiabank boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Eight equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus target price of $34.82.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.